Skip to content

Skin in Sight

Skin in Sight: a longitudinal cohort infrastructure for standardized remote monitoring and the evaluation of digital care innovations in chronic skin diseases - Skin in Sight

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON61413
Enrollment
1000
Registered
2026-05-12
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eczema/atopic dermatitis, psoriasis, hidradenitis suppurativa chronic skin diseases

Interventions

This study does not involve an investigational product or intervention. Participants receive standard care according to current clinical practice. The study uses a digital application as a data collec

Sponsors

Medisch Spectrum Twente (MST)
Lead Sponsor

Eligibility

Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosis of a chronic inflammatory skin disease (e.g. psoriasis, atopic dermatitis or hidradenitis suppurativa), as established by a dermatologistReceiving care at one of the participating centers at the time of inclusionWilling and able to participate in longitudinal monitoring, including completion of questionnaires and submission of standardized photographsSufficient proficiency in the Dutch language to understand study information and complete questionnaires (with support from parents or caregivers if applicable)Provision of written informed consent by the participant and/or legal representative (if applicable)16 years of age or older

Exclusion criteria

Exclusion criteria: Insufficient proficiency in the Dutch language, resulting in an inability to adequately understand the study information and/or complete questionnairesInability to participate in the study procedures, including completion of questionnaires or submission of photographs (e.g. due to cognitive or practical limitations)

Design outcomes

Primary

MeasureTime frame
Objective disease severity (PASI, EASI, IHS4/Hurley) assessed from standardized photographs, and PROMs including Skindex-29 and DLQI (quality of life), POEM (eczema symptoms), itch/pain NRS, CSQ-4 (quality of care) and PAM-13 (self-management capacity). Additionnaly, development and validation of predictive models (e.g. AI-based analysis of photographs for severity assessment)

Secondary

MeasureTime frame
Secondary parameters include exacerbations, healthcare use, therapy adherence and environmental exposures.

Countries

Netherlands

Contacts

Public ContactB.N.R. Kinderen

Medisch Spectrum Twente (MST)

huid-in-zicht@mst.nl06 55434587

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026